Synthesis of New Quinoxaline Pharmacophores as Antitumor Agents on MCF-7 breast cancer cells | ||||
| Alfarama Journal of Basic & Applied Sciences | ||||
| Articles in Press, Accepted Manuscript, Available Online from 24 February 2024 | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ajbas.2024.256230.1205 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Sara Adel Hegazy  1; El-Sherbiny Hamdi El-Sayed2; Ahmed Saad Saad3
| ||||
| 1Chemistry department, Faculty of science, portsaid university | ||||
| 2Department of Chemistry, Faculty of Science, Port Said University, Port Said, Egypt | ||||
| 3Pharmacology and Toxicology department, Faculty of Pharmacy, Port Said University, Port Said, Egypt | ||||
| Abstract | ||||
| A new first series from 2-substituted quinoxalines (3-6) were synthesized using o-phenylenediamine with aryl bromomethyl ketones as a key starting material. Moreover, a new second series from 2-oxo-1,2,3,4-tetrahydro-benzo [g] quinoxaline (8-10) were obtained from the reaction of naphthalene-2,3-diamine with ethyl chloroacetate. The structures of the two compound types were confirmed by spectral data studies along with elemental microanalysis. The cytotoxic effects of the synthesized compounds were tested using a MTT colorimetric assay in MCF-7 cells. Four of the compounds, given numbers 4, 5, 9 and 10, were found to induce significant levels of cytotoxicity. Compounds number 5 and 9 showed promising assay results and were tested in the non-cancerous cell line MCF-10A and neither of them showed cellular deterioration. Furthermore, compound 9 was reported to suppress tubulin polymerization. These findings were confirmed by the docking study results demonstrating a remarkable binding affinity of compound 9 to tubulin active site. These findings suggestes that compound 9 has a pharmacological potential as an antineoplastic drug in MCF-7 cells. | ||||
| Keywords | ||||
| Microtubules; Quinoxaline; Breast Cancer; Tubulin | ||||
|
Statistics Article View: 31 |
||||
